Portal de Periódicos da CAPES

Periodic Fever Syndromes

2011; Elsevier BV; Volume: 40; Issue: 1 Linguagem: Dinamarquês

10.3928/00904481-20101214-10

1938-2359

Victoria Wurster Ovalle, James G. Carlucci, Kathryn M. Edwards,

Dermatology and Skin Diseases

ArticlesPeriodic Fever Syndromes Victoria M. Wurster, BS, , , BS James G. Carlucci, MD, , and , MD Kathryn M. Edwards, MD, , MD Victoria M. Wurster, BS , James G. Carlucci, MD , and Kathryn M. Edwards, MD Published OnlineDecember 14, 2010https://doi.org/10.3928/00904481-20101214-10Cited by:7PDFView Full Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1.Reimann HA. Periodic disease; a probable syndrome including periodic fever, benign paroxysmal peritonitis, cyclic neutropenia and intermittent arthralgia. J Am Med Assoc. 1948; 136(4):239–244. Crossref MedlineGoogle Scholar2.Reimann HA, DeBerardinis CT. Periodic (cyclic) neutropenia, an entity; a collection of 16 cases. Blood. 1949; 4(10):1109–1116. Crossref MedlineGoogle Scholar3.Stoffman N, Magal N, Shohat T, et al.Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups. Eur J Hum Genet. 2000; 8(4):307–310.10.1038/sj.ejhg.5200446 Crossref MedlineGoogle Scholar4.Tunca M, Akar S, Onen F, et al.Turkish FMF Study Group. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005; 84(1):1–11.10.1097/01.md.0000152370.84628.0c Crossref MedlineGoogle Scholar5.Kallinich T, Wittkowski H, Keitzer R, Roth J, Foell D. Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever. Ann Rheum Dis. 2010; 69(4):677–682.10.1136/ard.2009.114363 Crossref MedlineGoogle Scholar6.Tunca M, Akar S, Soytürk M, et al.The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: A double-blind, placebo-controlled trial. Clin Exp Rheumatol. 2004; 22(4 Suppl 34):S37–S40. MedlineGoogle Scholar7.Seyahi E, Ozdogan H, Celik S, Ugurlu S, Yazici H. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents. Clin Exp Rheumatol. 2006; 24(5 Suppl 42):S99–S103. MedlineGoogle Scholar8.Onat AM, Oztürk MA, Ozçakar L, et al.Selective serotonin reuptake inhibitors reduce the attack frequency in familial Mediterranean fever. Tohoku J Exp Med. 2007; 211(1):9–14.10.1620/tjem.211.9 Crossref MedlineGoogle Scholar9.Houten SM, van Woerden CS, Wijburg FA, Wanders RJ, Waterham HR. Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands. Eur J Hum Genet. 2003; 11(2):196–200.10.1038/sj.ejhg.5200933 Crossref MedlineGoogle Scholar10.van der Hilst JC, Bodar EJ, Barron KS, et al.International HIDS Study Group. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore). 2008; 87(6):301–310.10.1097/MD.0b013e318190cfb7 Crossref MedlineGoogle Scholar11.Steichen O, van der Hilst J, Simon A, Cuisset L, Grateau G. A clinical criterion to exclude the hyperimmunoglobulin D syndrome (mild mevalonate kinase deficiency) in patients with recurrent fever. J Rheumatol. 2009; 36(8):1677–1681.10.3899/jrheum.081313 Crossref MedlineGoogle Scholar12.Drenth JP, Vonk AG, Simon A, Powell R, van der Meer JW. Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial. J Pharmacol Exp Ther. 2001; 298(3):1221–1226. MedlineGoogle Scholar13.Simon A, Drewe E, van der Meer JW, et al.Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther. 2004; 75(5):476–483.10.1016/j.clpt.2004.01.012 Crossref MedlineGoogle Scholar14.Bodar EJ, van der Hilst JC, Drenth JP, van der Meer JW, Simon A. Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med. 2005; 63(7):260–264. MedlineGoogle Scholar15.Rigante D, Ansuini V, Bertoni B, Pugliese AL, Avallone L, Federico G, Stabile A. Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome. Rheumatol Int. 2006; 27(1):97–100.10.1007/s00296-006-0164-x Crossref MedlineGoogle Scholar16.Aksentijevich I, Galon J, Soares M, et al.The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet. 2001; 69(2):301–314.10.1086/321976 Crossref MedlineGoogle Scholar17.Hull KM, Drewe E, Aksentijevich I, et al.The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore). 2002; 81(5):349–368.10.1097/00005792-200209000-00002 Crossref MedlineGoogle Scholar18.Simon A, Bodar EJ, van der Hilst JC, et al.Beneficial response to interleukin 1 receptor antagonist in traps. Am J Med. 2004; 117(3):208–210.10.1016/j.amjmed.2004.02.039 Crossref MedlineGoogle Scholar19.Gattorno M, Pelagatti MA, Meini A, et al.Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 2008; 58(5):1516–1520.10.1002/art.23475 Crossref MedlineGoogle Scholar20.Boxer LA, Stein S, Buckley D, Bolyard AA, Dale DC. Strong evidence for autosomal dominant inheritance of severe congenital neutropenia associated with ELA2 mutations. J Pediatr. 2006May; 148(5):633–636.10.1016/j.jpeds.2005.12.029 Crossref MedlineGoogle Scholar21.Dale DC, Bolyard AA, Aprikyan A. Cyclic neutropenia. Semin Hematol. 2002; 39(2):89–94.10.1053/shem.2002.31917 Crossref MedlineGoogle Scholar22.Hammond WP, Price TH, Souza LM, Dale DC. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med. 1989; 320(20):1306–1311.10.1056/NEJM198905183202003 Crossref MedlineGoogle Scholar23.Hawkins PN, Lachmann HJ, McDermott MF. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med. 2003; 348(25):2583–2584.10.1056/NEJM200306193482523 Crossref MedlineGoogle Scholar24.Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muck-le-Wells syndrome and response to anakinra. Arthritis Rheum. 2004; 50(2):607–612.10.1002/art.20033 Crossref MedlineGoogle Scholar25.Dailey NJ, Aksentijevich I, Chae JJ, et al.Interleukin-1 receptor antagonist anakinra in the treatment of neonatal onset multisystem inflammatory disease. Arthritis Rheum. 2004; 50:S440. Google Scholar26.Goldbach-Mansky R, Dailey NJ, Canna SW, et al.Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med. 2006; 355(6):581–592.10.1056/NEJMoa055137 Crossref MedlineGoogle Scholar27.Dagan E, Gershoni-Baruch R, Khatib I, Mori A, Brik R. MEFV, TNF1rA, CARD15 and NLRP3 mutation analysis in PFAPA. Rheumatol Int. 2010; 30(5):633–636.10.1007/s00296-009-1037-x Crossref MedlineGoogle Scholar28.Gattorno M, Caorsi R, Meini A, et al.Differentiating PFAPA syndrome from monogenic periodic fevers. Pediatrics. 2009; 124(4):e721–e728.10.1542/peds.2009-0088 Crossref MedlineGoogle Scholar29.Cochard M, Clet J, Le L, et al.PFAPA syndrome is not a sporadic disease. Rheumatology (Oxford). 2010; 49(10):1984–1987.10.1093/rheumatology/keq187 Crossref MedlineGoogle Scholar30.Sampaio IC, Rodrigo MJ, Monteiro Marques JG. Two siblings with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome. Pediatr Infect Dis J. 2009; 28(3):254–255.10.1097/INF.0b013e31818c8ea5 Crossref MedlineGoogle Scholar31.Valenzuela PM, Majerson D, Tapia JL, Talesnik E. Syndrome of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) in siblings. Clin Rheumatol. 2009; 28(10):1235–1237.10.1007/s10067-009-1222-z Crossref MedlineGoogle Scholar32.Marshall GS, Edwards KM, Lawton AR. PFAPA syndrome. Pediatr Infect Dis J. 1989; 8(9):658–659. Crossref MedlineGoogle Scholar33.Thomas KT, Feder HM, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr. 1999; 135(1):15–21.10.1016/S0022-3476(99)70321-5 Crossref MedlineGoogle Scholar34.Stojanov S, Hoffmann F, Kéry A, et al.Cytokine profile in PFAPA syndrome suggests continuous inflammation and reduced anti-inflammatory response. Eur Cytokine Netw. 2006; 17(2):90–97. MedlineGoogle Scholar35.Garavello W, Romagnoli M, Gaini RM. Effectiveness of adenotonsillectomy in PFAPA syndrome: a randomized study. J Pediatr. 2009; 155(2):250–253.10.1016/j.jpeds.2009.02.038 Crossref MedlineGoogle Scholar36.Renko M, Salo E, Putto-Laurila A, et al.A randomized, controlled trial of tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome. J Pediatr. 2007; 151(3):289–292.10.1016/j.jpeds.2007.03.015 Crossref MedlineGoogle Scholar37.Burton MJ, Pollard AJ, Ramsden JD. Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA). Cochrane Database Syst Rev. 2010;(9):CD008669. MedlineGoogle Scholar38.Gattorno M, Sormani MP, D'Osualdo A, et al.A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. Arthritis Rheum. 2008; 58(6):1823–1832.10.1002/art.23474 Crossref MedlineGoogle Scholar39.Shinkai K, Kilcline C, Connolly MK, Frieden IJ. The pyrin family of fever genes: unmasking genetic determinants of autoinflammatory disease. Arch Dermatol. 2005; 141(2):242–247.10.1001/archderm.141.2.242 Crossref MedlineGoogle Scholar Previous article FiguresReferencesRelatedDetailsCited by Kotsanos N, Marks L, Arapostathis K and Kubota K (2022) Disabilities, Neuropsychiatric Disorders, and Syndromes in Childhood and Adolescence Pediatric Dentistry, 10.1007/978-3-030-78003-6_22, (527-552), . Bryant P and South M (2013) Fifteen-minute consultation: the infant with frequent infections: Table 1, Archives of disease in childhood - Education & practice edition, 10.1136/archdischild-2013-303971, 99:1, (8-12), Online publication date: 1-Feb-2014. Sherman J and Sood S (2012) Current challenges in the diagnosis and management of fever, Current Opinion in Pediatrics, 10.1097/MOP.0b013e32835333e3, 24:3, (400-406), Online publication date: 1-Jun-2012. Kastner D (2012) The Systemic Autoinflammatory Diseases Goldman's Cecil Medicine, 10.1016/B978-1-4377-1604-7.00269-4, (1667-1672), . Prasad C, Salvadori M and Rupar C (2012) Severe phenotypic spectrum of mevalonate kinase deficiency with minimal mevalonic aciduria, Molecular Genetics and Metabolism, 10.1016/j.ymgme.2012.10.019, 107:4, (756-759), Online publication date: 1-Dec-2012. Giancane G, Cortis E, Ernesti I, Di Coste A and Duse M (2012) Dalle immunodeficienze alle malattie reumatologiche, Area Pediatrica, 10.1016/j.arped.2012.10.005, 13:4, (111-116), Online publication date: 1-Oct-2012. Parrado Sánchez Z, Cárdenas Hernández V, Medina Rivera S and Márquez Herrera K (2020) Fiebre periódica en pediatría : abordaje ambulatorio., Revista Ciencias Biomédicas, 10.32997/rcb-2020-3042, 9:1, (44-53) Request Permissions InformationCopyright 2011, SLACK IncorporatedPDF downloadAddress correspondence to: Kathryn M. Edwards, MD; fax: 615-343-9723; or e-mail: kath-ryn.[email protected]edu.Victoria M. Wurster, BS; James G. Carlucci, MD; and Kathryn M. Edwards, MD, are with Vanderbilt University School of Medicine, Department of Pediatrics, Division of Pediatric Infectious Diseases.Ms. Wurster and Dr. Carlucci have disclosed no relevant financial relationships. Dr. Edwards has disclosed the following relevant financial relationships: Centers for Disease Cotnrol and Prevention, National Institutes of Health, and Novartis: Contracted research recipient.